内镜外科技术认证体系对胃癌腹腔镜胃切除术肿瘤学安全性的影响:单中心回顾性队列研究
该单中心回顾性队列研究纳入2009年1月至2019年6月接受腹腔镜胃切除术的临床和病理分期≤III期胃癌患者1030例,经倾向性评分匹配后比较非ESSQS认证医师在ESSQS认证医师指导下与ESSQS认证医师主刀的手术肿瘤学结局。结果显示非ESSQS组3年无复发生存率84.4%对81.7%,差异2.7%(95%CI -3.20%~8.44%,P<0.001),达到非劣效终点;5年无复发生存率和总生存率两组无显著差异。
要点
- 非ESSQS认证医师在认证医师指导下行腹腔镜胃切除术,3年无复发生存非劣效于认证医师。
- 两组5年无复发生存率(78.5% vs 77.4%,P=0.627)和5年总生存率(80.9% vs 79.3%,P=0.475)无显著差异。
- 按病理I、II、III期分层,两组肿瘤学结局均无显著差异。
核心结论
- 在高容量中心,只要ESSQS认证医师提供术中指导,非ESSQS认证医师行腹腔镜胃切除术可获得与认证医师相当的肿瘤学结局。
研究设计与样本
- 单中心回顾性队列研究,纳入2009年1月至2019年6月临床和病理分期≤III期且行腹腔镜胃切除术的胃癌患者1030例,采用倾向性评分匹配比较非ESSQS认证与ESSQS认证医师组,匹配后每组315对。
主要发现
- 非ESSQS组与ESSQS组3年无复发生存率分别为84.4%和81.7%,差异2.7%(95%CI -3.20%~8.44%,P<0.001),非ESSQS组达到非劣效性。
- 两组5年无复发生存率分别为78.5%和77.4%(P=0.627),5年总生存率分别为80.9%和79.3%(P=0.475),均无显著差异。
- 按病理分期I、II、III期分层,两组肿瘤学结局无显著差异。
关键数值与推荐
- 非劣效界值预设为-10%,非ESSQS组3年无复发生存率差异的95%置信区间下限(-3.20%)大于-10%,达到主要终点。
临床怎么用
- 在高容量中心,非ESSQS认证医师可在ESSQS认证医师术中指导下安全开展腹腔镜胃切除术,肿瘤学结局与认证医师相当。
局限性
- 本研究为单中心回顾性研究,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to investigate the laparoscopic gastrectomy (LG) performance of non-Endoscopic Surgical Skill Qualification System (ESSQS)-qualified surgeons under the ESSQS-qualified surgeon guidance and compare oncological outcomes of gastric cancer to LG performed by the ESSQS-qualified surgeons. METHODS: This study enrolled 1,030 patients diagnosed with both clinical and pathological stage ≤ III gastric cancer and undergoing LG from January 2009 to June 2019. ESSQS-qualified surgeons served as the operator or the instructive assistant in all LG procedures involving them. A propensity score-matched analysis was used to retrospectively compare the long-term outcomes between the ESSQS-qualified and non-ESSQS-qualified surgeons. RESULTS: Each group included 315 pairs after propensity score matching. The 3-year recurrence-free survival rates were 84.4% and 81.7% in the non-ESSQS and ESSQS groups, respectively. The difference was 2.7% (95% confidence interval: - 3.20%-8.44%, P < 0.001), and the non-ESSQS group statistically demonstrated noninferiority as the lower 95% confidence limit was greater than the prespecified margin of -10%, indicating the achieved primary endpoint. No significant differences in 5-year recurrence-free survival (non-ESSQS: 78.5% vs. ESSQS: 77.4%, P = 0.627) and 5-year overall survival (non-ESSQS: 80.9% vs. ESSQS: 79.3%, P = 0.475) were found between the two groups. The oncological outcomes stratified according to the presence of pathological stage I, II, and III disease did not significantly differ between the two groups. CONCLUSIONS: LG performed by non-ESSQS-qualified surgeons achieved comparable oncological outcomes to the ESSQS-qualified surgeons, as long as ESSQS-qualified surgeons provided intraoperative instructions, in a high-volume center.
引用
- Ito A, Shibasaki S, Inoue S, et al. Impact of the endoscopic surgical skill qualification system on the oncological safety of laparoscopic gastrectomy for gastric cancer: A single-center retrospective cohort study. Surg Endosc. 2024. PMID: 39134723. doi:10.1007/s00464-024-11153-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。